About this trial
This study aims to evaluate the concept of closed-loop treatment of atrial fibrillation for the optimization of the treatment strategy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
atrial fibrillation patients;Ability to act autonomously, understand and sign informed consent;
Disqualifiers
none(All patients with atrial fibrillation were enrolled in this study indiscriminately and followed up)
Trial population
Atrial fibrillation patients in North Shanghai area.
Trial design
Cohort
Prospective
Treatments tested in this trial
Radiofrequency ablation
Procedure/SurgeryCombined use of radiofrequency ablation, cryoablation, left bundle branch pacing, and left atrial appendage closure according to the actual situation of the patient.
Treatment groups
Trial outcomes
Primary outcomes
Atrial fibrillation recurrence
The recurrence of atrial fibrillation and the degree of burden of atrial fibrillation in patients.
Heart failure
Degree of heart failure (including EF%, NYHA score, etc.)
Stroke
stroke attack(Check for new cerebral infarction by MRI)
Secondary outcomes
bleeding
major bleeding event
Cardiovascular MACE events
Cardiovascular MACE events
Sponsors and contacts
Click on the lead sponsor to view all of their trials.